Due to the treatment application of synthetic PPAR gamma ligand used in insulin resistance therapy in PCOS population, it can be assumed that dietary PUFAs may play a role in the reduction of insulin resistance (Kasim-Karakas et al., 2004[34]). This evidence concerns the gene PPARG and Insulin resistance.